Publications decrying the resistance of thromboembolic disease to medical intervention.

Table 1: Publications decrying the resistance of thromboembolic disease to medical intervention.

Inadequacy of osocimab and apixaban for prevention of post-surgical thromboembolic complications [12].

Inadequacy of standard aspirin doses, low molecular heparin and factor Xa inhibitor in preventing or resolving post-surgical thrombotic events [13,14].

Inadequacy of low molecular heparin and factor Xa inhibitor in preventing hemophilia-induced tissue damage [15].

Inadequacy of low molecular heparin and factor Xa inhibitor in preventing space-flight related thrombotic events [16].

Inadequacy of traditional low dose aspirin in preventing thromboembolic disease [17].

Inadequacy of standard anticoagulation doses to prevent thromboembolic disease in high risk patients [18].